A mutant BRAF V600E-specific immunohistochemical assay: correlation with molecular mutation status and clinical outcome in colorectal cancer
Fiona Day, Andrea Muranyi, Shalini Singh, Kandavel Shanmugam, David Williams, David Byrne, Kym Pham, Michelle Palmieri, Jeanne Tie, Thomas Grogan, Peter Gibbs, Oliver Sieber, Paul Waring, Jayesh Desai
Targeted Oncology | SPRINGER | Published : 2015
This study was supported by the Victorian Government through the Operational Infrastructure Support Program, the Victorian Cancer Agency and the Australian Government through the National Health Medical Research Council and Ventana Medical Systems, Inc. J.D. is supported by the Victorian Government through a Victorian Cancer Agency Clinical Researcher Fellowship. F.D. is supported by the Cancer Council Victoria through a Postgraduate Cancer Research Scholarship.